152 related articles for article (PubMed ID: 14669276)
1. Prostate carcinoma tissue proteomics for biomarker discovery.
Zheng Y; Xu Y; Ye B; Lei J; Weinstein MH; O'Leary MP; Richie JP; Mok SC; Liu BC
Cancer; 2003 Dec; 98(12):2576-82. PubMed ID: 14669276
[TBL] [Abstract][Full Text] [Related]
2. New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics.
Paweletz CP; Liotta LA; Petricoin EF
Urology; 2001 Apr; 57(4 Suppl 1):160-3. PubMed ID: 11295617
[TBL] [Abstract][Full Text] [Related]
3. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.
Cazares LH; Adam BL; Ward MD; Nasim S; Schellhammer PF; Semmes OJ; Wright GL
Clin Cancer Res; 2002 Aug; 8(8):2541-52. PubMed ID: 12171882
[TBL] [Abstract][Full Text] [Related]
4. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of formalin-fixed prostate cancer tissue.
Hood BL; Darfler MM; Guiel TG; Furusato B; Lucas DA; Ringeisen BR; Sesterhenn IA; Conrads TP; Veenstra TD; Krizman DB
Mol Cell Proteomics; 2005 Nov; 4(11):1741-53. PubMed ID: 16091476
[TBL] [Abstract][Full Text] [Related]
6. The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.
Wang X; Han J; Hardie DB; Yang J; Borchers CH
J Mass Spectrom; 2016 Jan; 51(1):86-95. PubMed ID: 26757076
[TBL] [Abstract][Full Text] [Related]
7. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
8. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
[TBL] [Abstract][Full Text] [Related]
9. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.
Ornstein DK; Rayford W; Fusaro VA; Conrads TP; Ross SJ; Hitt BA; Wiggins WW; Veenstra TD; Liotta LA; Petricoin EF
J Urol; 2004 Oct; 172(4 Pt 1):1302-5. PubMed ID: 15371828
[TBL] [Abstract][Full Text] [Related]
10. Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection.
Simone NL; Remaley AT; Charboneau L; Petricoin EF; Glickman JW; Emmert-Buck MR; Fleisher TA; Liotta LA
Am J Pathol; 2000 Feb; 156(2):445-52. PubMed ID: 10666374
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma.
Kim ED; Smith ND; Grayhack JT
J Urol; 1995 Nov; 154(5):1802-5. PubMed ID: 7563351
[TBL] [Abstract][Full Text] [Related]
12. Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium.
Ornstein DK; Englert C; Gillespie JW; Paweletz CP; Linehan WM; Emmert-Buck MR; Petricoin EF
Clin Cancer Res; 2000 Feb; 6(2):353-6. PubMed ID: 10690510
[TBL] [Abstract][Full Text] [Related]
13. PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R
Pathol Biol (Paris); 2014 Jun; 62(3):129-36. PubMed ID: 24745345
[TBL] [Abstract][Full Text] [Related]
14. Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry.
Alaiya AA; Oppermann M; Langridge J; Roblick U; Egevad L; Brindstedt S; Hellström M; Linder S; Bergman T; Jörnvall H; Auer G
Cell Mol Life Sci; 2001 Feb; 58(2):307-11. PubMed ID: 11289312
[TBL] [Abstract][Full Text] [Related]
15. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
[TBL] [Abstract][Full Text] [Related]
16. MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer.
Pallua JD; Schaefer G; Seifarth C; Becker M; Meding S; Rauser S; Walch A; Handler M; Netzer M; Popovscaia M; Osl M; Baumgartner C; Lindner H; Kremser L; Sarg B; Bartsch G; Huck CW; Bonn GK; Klocker H
J Proteomics; 2013 Oct; 91():500-14. PubMed ID: 23954705
[TBL] [Abstract][Full Text] [Related]
17. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.
Adam BL; Qu Y; Davis JW; Ward MD; Clements MA; Cazares LH; Semmes OJ; Schellhammer PF; Yasui Y; Feng Z; Wright GL
Cancer Res; 2002 Jul; 62(13):3609-14. PubMed ID: 12097261
[TBL] [Abstract][Full Text] [Related]
18. The problem of cutoff levels in a screened population: appropriateness of informing screenees about their risk of having prostate carcinoma.
Horninger W; Bartsch G; Snow PB; Brandt JM; Partin AW
Cancer; 2001 Apr; 91(8 Suppl):1667-72. PubMed ID: 11309766
[TBL] [Abstract][Full Text] [Related]
19. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
20. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications.
Jung K; Brux B; Lein M; Rudolph B; Kristiansen G; Hauptmann S; Schnorr D; Loening SA; Sinha P
Clin Chem; 2000 Jan; 46(1):47-54. PubMed ID: 10620571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
